Cargando…

Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)

INTRODUCTION: Hepatitis B and C represent an important co-infection for people living with HIV worldwide. Nepal wants to be part of the international mobilization for viral hepatitis elimination, and has pursued better understanding of the epidemic in its territory through scientific research. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveira, Marcelo Contardo Moscoso, Badal, Komal, Dhakal, Jagadish, Mayer, Neichu Angami, Pokharel, Bina, Del Prado, Ruben Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126038/
https://www.ncbi.nlm.nih.gov/pubmed/30288333
http://dx.doi.org/10.1186/s41124-018-0039-2
_version_ 1783353261293568000
author Naveira, Marcelo Contardo Moscoso
Badal, Komal
Dhakal, Jagadish
Mayer, Neichu Angami
Pokharel, Bina
Del Prado, Ruben Frank
author_facet Naveira, Marcelo Contardo Moscoso
Badal, Komal
Dhakal, Jagadish
Mayer, Neichu Angami
Pokharel, Bina
Del Prado, Ruben Frank
author_sort Naveira, Marcelo Contardo Moscoso
collection PubMed
description INTRODUCTION: Hepatitis B and C represent an important co-infection for people living with HIV worldwide. Nepal wants to be part of the international mobilization for viral hepatitis elimination, and has pursued better understanding of the epidemic in its territory through scientific research. METHODS: We performed a systematic review of seroprevalence studies hepatitis B and C in Nepal following the PRISMA 2009 Flow Diagram. RESULTS: Fifty-four scientific publications and reports were selected for this review. Nearly a quarter of these documents have been issued in recent years and many are authored by non-governmental organizations in Nepal. The collective of information displays a wide range of alarming prevalence rates, particularly for girls and women survivors of human trafficking and a progressive participation of civil society in viral hepatitis epidemiology research in the country. CONCLUSION: This paper presents a most complete review of hepatitis B and C and HIV co-infection prevalence studies in different population groups from 1973 to 2016. A comprehensive analysis of the epidemiology and apparent trends in public health research and policy making in Nepal are also addressed in this document. We expect this to be a most important tool for improvements in future interventions for both epidemics in the country.
format Online
Article
Text
id pubmed-6126038
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61260382018-10-04 Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017) Naveira, Marcelo Contardo Moscoso Badal, Komal Dhakal, Jagadish Mayer, Neichu Angami Pokharel, Bina Del Prado, Ruben Frank Hepatol Med Policy Review INTRODUCTION: Hepatitis B and C represent an important co-infection for people living with HIV worldwide. Nepal wants to be part of the international mobilization for viral hepatitis elimination, and has pursued better understanding of the epidemic in its territory through scientific research. METHODS: We performed a systematic review of seroprevalence studies hepatitis B and C in Nepal following the PRISMA 2009 Flow Diagram. RESULTS: Fifty-four scientific publications and reports were selected for this review. Nearly a quarter of these documents have been issued in recent years and many are authored by non-governmental organizations in Nepal. The collective of information displays a wide range of alarming prevalence rates, particularly for girls and women survivors of human trafficking and a progressive participation of civil society in viral hepatitis epidemiology research in the country. CONCLUSION: This paper presents a most complete review of hepatitis B and C and HIV co-infection prevalence studies in different population groups from 1973 to 2016. A comprehensive analysis of the epidemiology and apparent trends in public health research and policy making in Nepal are also addressed in this document. We expect this to be a most important tool for improvements in future interventions for both epidemics in the country. BioMed Central 2018-09-06 /pmc/articles/PMC6126038/ /pubmed/30288333 http://dx.doi.org/10.1186/s41124-018-0039-2 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Naveira, Marcelo Contardo Moscoso
Badal, Komal
Dhakal, Jagadish
Mayer, Neichu Angami
Pokharel, Bina
Del Prado, Ruben Frank
Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title_full Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title_fullStr Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title_full_unstemmed Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title_short Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017)
title_sort seroprevalence of hepatitis b and c in nepal: a systematic review (1973–2017)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126038/
https://www.ncbi.nlm.nih.gov/pubmed/30288333
http://dx.doi.org/10.1186/s41124-018-0039-2
work_keys_str_mv AT naveiramarcelocontardomoscoso seroprevalenceofhepatitisbandcinnepalasystematicreview19732017
AT badalkomal seroprevalenceofhepatitisbandcinnepalasystematicreview19732017
AT dhakaljagadish seroprevalenceofhepatitisbandcinnepalasystematicreview19732017
AT mayerneichuangami seroprevalenceofhepatitisbandcinnepalasystematicreview19732017
AT pokharelbina seroprevalenceofhepatitisbandcinnepalasystematicreview19732017
AT delpradorubenfrank seroprevalenceofhepatitisbandcinnepalasystematicreview19732017